Doctors Note Logo

Published on: 4/29/2026

Why is your recovery stalled? Why leukocyte-rich vs poor PRP is your medically approved next step.

Persistent inflammation, poor blood flow, excess scar tissue and incomplete rehabilitation can keep your recovery stalled, even after rest and therapy.

Platelet rich plasma can jump start healing, and choosing leukocyte rich versus leukocyte poor PRP is critical since the former boosts inflammation for chronic lesions and the latter minimizes flare ups for acute or joint issues. See below for details on the factors that will guide the right PRP choice for your condition.

answer background

Explanation

Why Is Your Recovery Stalled?

Understanding the Roadblocks

It's frustrating when you've followed your rehab plan to the letter—physical therapy, rest, medications—and still feel stuck. Before you write off further improvement, it helps to know the common reasons recovery plateaus:

  • Chronic inflammation
    After an injury or surgery, your body's inflammatory response should taper off. When it persists, it hinders tissue repair and fuels pain.
  • Poor blood flow
    Adequate circulation delivers oxygen and nutrients that healing tissues need. Scar tissue or persistent swelling can reduce local blood flow.
  • Scar formation and fibrosis
    Excessive scar tissue restricts movement and can pinch nerves. Over time, this may perpetuate pain and limit function.
  • Incomplete rehabilitation
    Skipping certain exercises or returning to activity too quickly can leave underlying weaknesses unaddressed.
  • Systemic factors
    Age, diabetes, smoking, nutritional deficiencies and chronic stress all slow down healing.

If you've checked off every standard intervention but still aren't back to your old self, you may be a candidate for a targeted biologic approach: platelet-rich plasma (PRP) therapy.


Platelet-Rich Plasma: A Brief Overview

PRP is a concentration of your own blood platelets, rich in growth factors that can jump-start the healing process. A small amount of blood is drawn, spun in a centrifuge, and separated into:

  • Platelet-poor plasma
    Mostly fluid, with few platelets.
  • Platelet-rich plasma
    A thicker layer with 3–5× the normal platelet count.

Depending on how the sample is processed, PRP can be further classified by its white blood cell (leukocyte) content:

  • Leukocyte-rich PRP (LR-PRP)
    Contains both platelets and a higher concentration of white blood cells.
  • Leukocyte-poor PRP (LP-PRP)
    Filtered to remove most white blood cells, leaving mainly platelets.

Both types deliver growth factors such as PDGF, TGF-β, VEGF and others that:

  • Attract reparative cells
  • Promote new blood vessel formation
  • Stimulate collagen and extracellular matrix production

Yet the presence or absence of leukocytes can tip the balance toward more or less inflammation.


Leukocyte-Rich vs. Leukocyte-Poor PRP: What's the Difference?

Feature Leukocyte-Rich PRP (LR-PRP) Leukocyte-Poor PRP (LP-PRP)
White blood cell count High Low
Inflammatory potential Higher (more cytokines) Lower (less cytokines)
Ideal for Chronic tendinopathies, slow-healing wounds Acute soft-tissue injuries, joints (e.g. osteoarthritis)
Risk of flare-up Moderate (transient increase in pain) Low
Growth factor profile Broader (includes WBC-mediated factors) Focused on platelet factors

Key takeaways:

  • LR-PRP harnesses both platelets and leukocytes. The extra cytokines can boost early inflammation, which—when properly timed—serves as a trigger for healing in stubborn, chronic conditions.
  • LP-PRP minimizes inflammatory byproducts, making it gentler on sensitive areas like arthritic joints.

When to Consider Each Type

Leukocyte-Rich PRP

Best for conditions characterized by long-standing degeneration or scarring, where reigniting a healing cascade is critical:

  • Chronic tendinopathies (e.g., tennis elbow, Achilles tendinitis)
  • Non-healing wounds or ulcers
  • Muscle strains with significant fibrosis
  • Bone healing (as an adjunct in delayed union)

Pros:

  • Strong pro-inflammatory signal to restart healing
  • Broader mix of growth factors and chemokines

Cons:

  • May cause a transient increase in pain or swelling
  • Not ideal for already inflamed joints

Leukocyte-Poor PRP

Suited to situations where you want growth factors without the extra inflammatory surge:

  • Early-stage osteoarthritis (knee, hip, shoulder)
  • Fresh soft-tissue injuries (muscle strains, ligament sprains)
  • Patients sensitive to inflammation or with rheumatoid conditions

Pros:

  • Lower risk of flare-up pain or swelling
  • Targeted delivery of platelet-derived factors

Cons:

  • May be less effective at "jump-starting" very chronic lesions

Evidence and Guidelines

  • A 2021 systematic review in the American Journal of Sports Medicine found LR-PRP more effective than LP-PRP for chronic tendinopathies, while LP-PRP had better short-term results in knee osteoarthritis.
  • The American Academy of Orthopaedic Surgeons notes that PRP is "likely beneficial" for certain soft-tissue injuries, but emphasizes matching the formulation to the condition.
  • A 2022 meta-analysis in Regenerative Therapy highlighted fewer adverse events and better pain relief in LP-PRP for joint applications.

How to Proceed Medically

  1. Consult a specialist
    An orthopaedist, sports medicine physician or physiatrist can assess your history, imaging and physical exam to determine which PRP type fits your condition.

  2. Review your goals
    Are you aiming for pain relief, improved function, or both? Chronic cases often benefit from LR-PRP; acute or joint-focused issues lean toward LP-PRP.

  3. Plan the protocol

    • Number of injections (usually 1–3, spaced 4–6 weeks apart)
    • Injection technique (ultrasound guidance for precision)
    • Post-procedure care (activity modification, physical therapy)
  4. Monitor progress
    Track pain, function and any side effects. Adjust the plan as needed with your physician.


Next Steps

If you're still wondering whether PRP could break through your recovery plateau, get personalized insights by using Ubie's Medically Approved AI Symptom Checker to document your symptoms, track your recovery progress, and prepare informed questions before your specialist appointment.


Final Thoughts

Platelet-rich plasma offers a personalized, biologic boost to healing—but not all PRP is the same. Understanding the differences between leukocyte-rich vs. leukocyte-poor PRP helps you and your physician choose the right tool for your stalled recovery. Don't let frustration hold you back. Seek expert evaluation, discuss the pros and cons of each PRP type, and chart a clear path forward.

If you're experiencing any severe, life-threatening or rapidly worsening symptoms, please speak to a doctor right away. Your health deserves professional attention.

(References)

  • * Fitzpatrick J, Bessa W, Maerz T, Schuchert M, Al-Humairi B, Bartol S, Verner JJ, Al-Shaikh R, Vaidya R. Leukocyte-rich versus leukocyte-poor platelet-rich plasma: a comprehensive review of the current evidence. J Orthop Surg Res. 2021 Jul 27;16(1):475. doi: 10.1186/s13018-021-02613-6. PMID: 34311853; PMCID: PMC8315180.

  • * Somani A, Sharma R, Sharma V, Patel V, Nimbulkar S, Gopinathan NR, Singh R. Platelet-Rich Plasma (PRP) in Stalled Wound Healing: A Narrative Review. Cureus. 2023 Apr 1;15(4):e36979. doi: 10.7759/cureus.36979. PMID: 37131846; PMCID: PMC10148762.

  • * Lana JF, Silva R, Annunziata RP, Luzo MV, Barreto AP, Kfuri M Jr. The Role of Leukocytes in Platelet-Rich Plasma: A Systematic Review of Basic Science and Clinical Evidence. Cartilage. 2021 Oct;13(1_suppl):1643S-1655S. doi: 10.1177/19476035211025752. PMID: 34749666; PMCID: PMC8719283.

  • * Lee DW, Han Y, Cho YH, Lim JM, Kim JW, Park JS. Biological effects of platelet-rich plasma, leukocyte-rich plasma, and leukocyte-poor plasma on human tendinocytes: a comparative in vitro study. J Orthop Surg Res. 2021 Apr 22;16(1):267. doi: 10.1186/s13018-021-02409-7. PMID: 33888061; PMCID: PMC8061619.

  • * Gupta A, Singh P, Kumar R, Kumar A, Kumar P, Srivastava R, Tripathi V, Pathak RK, Singh U. Leukocyte-rich vs. Leukocyte-poor Platelet-Rich Plasma in Musculoskeletal Diseases: A Systematic Review of Current Evidence and Clinical Recommendations. J Clin Orthop Trauma. 2023 Apr;42:102298. doi: 10.1016/j.jcot.2023.102298. Epub 2023 Mar 9. PMID: 37063231; PMCID: PMC10098495.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.